Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berinert in Deceased-Donor Kidney Transplant
NCT06919003Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2025
- Primary completion
- May 2031
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of c1-esterase inhibitor in kidney transplantation, sponsored by National Institute of Allergy and Infectious Diseases. Started Sep 2025; status: recruiting.
02
Drugs
c1-esterase inhibitor
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT06919003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06919003.